Even PhRMA can't spin this
From O'Dwyer's PR Blog: The Vytorin controversy is just icing on a (low cholesterol) cake for those upset with the barrage of drug advertising, and the promotion of "quasi diseases" by big pharmaceutical houses. It's a safe bet the Congress is going to step up efforts to reg